299 related articles for article (PubMed ID: 25017461)
1. Contraceptive use in acne.
Lam C; Zaenglein AL
Clin Dermatol; 2014; 32(4):502-15. PubMed ID: 25017461
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Acne Therapy, Part 2: Hormonal Therapy and Isotretinoin.
Marson JW; Baldwin HE
Dermatol Clin; 2019 Apr; 37(2):195-203. PubMed ID: 30850042
[TBL] [Abstract][Full Text] [Related]
3. The use of hormonal agents in the treatment of acne.
Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
5. Treating Acne in Adult Women.
Harper JC; Stein Gold LF; Alexis AF; Tan JKL
Semin Cutan Med Surg; 2018 Jun; 37(3S):S67-S70. PubMed ID: 30192345
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapy for acne using oral contraceptive pills.
Harper JC
Semin Cutan Med Surg; 2005 Jun; 24(2):103-6. PubMed ID: 16092798
[TBL] [Abstract][Full Text] [Related]
7. Should dermatologists prescribe hormonal contraceptives for acne?
Harper JC
Dermatol Ther; 2009; 22(5):452-7. PubMed ID: 19845722
[TBL] [Abstract][Full Text] [Related]
8. Acne: effect of hormones on pathogenesis and management.
Shaw JC
Am J Clin Dermatol; 2002; 3(8):571-8. PubMed ID: 12358558
[TBL] [Abstract][Full Text] [Related]
9. Update and future of hormonal therapy in acne.
Thiboutot D; Chen W
Dermatology; 2003; 206(1):57-67. PubMed ID: 12566806
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
11. Adult female acne treated with spironolactone: a retrospective data review of 70 cases.
Isvy-Joubert A; Nguyen JM; Gaultier A; Saint-Jean M; Le Moigne M; Boisrobert E; Khammari A; Dreno B
Eur J Dermatol; 2017 Aug; 27(4):393-398. PubMed ID: 28862134
[TBL] [Abstract][Full Text] [Related]
12. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Lee O; Farquhar C; Toomath R; Jepson R
Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy for acne.
George R; Clarke S; Thiboutot D
Semin Cutan Med Surg; 2008 Sep; 27(3):188-96. PubMed ID: 18786497
[TBL] [Abstract][Full Text] [Related]
16. Combined oral contraceptives for the treatment of acne: a practical guide.
Arrington EA; Patel NS; Gerancher K; Feldman SR
Cutis; 2012 Aug; 90(2):83-90. PubMed ID: 22988652
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
18. Use of systemic agents in the treatment of acne vulgaris.
Johnson BA; Nunley JR
Am Fam Physician; 2000 Oct; 62(8):1823-30, 1835-6. PubMed ID: 11057839
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
Katsambas AD; Dessinioti C
Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
[TBL] [Abstract][Full Text] [Related]
20. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
